The estimated net worth of Mr. Patrick R. O'Neil is at least $22,692,717 as of 2 Feb 2024. He owns shares worth
$2,067,119 as insider, has earned $10,750,438
from insider trading and has received compensation worth at least
$9,875,160 in Ionis Pharmaceuticals, Inc..
What is the salary of Patrick R. O'Neil?
Mr. Patrick R. O'Neil salary is $822,930 per year
as Executive Vice President, Chief Legal Officer & Gen. Counsel in Ionis Pharmaceuticals, Inc..
How old is Patrick R. O'Neil?
Mr. Patrick R. O'Neil is 51 years old, born in 1974.
What stocks does Patrick R. O'Neil currently own?
As insider, Mr. Patrick R. O'Neil owns shares in one company:
Executive Vice President, Chief Legal Officer & Gen. Counsel
48,661
$42.48
$2,067,119
What does Ionis Pharmaceuticals, Inc. do?
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.
Mr. Patrick R. O'Neil has made 76 insider trades between 2013-2024, according to the Form 4 filled with the SEC. Most recently he sold
1,961 units of IONS stock worth $97,411 on 2 Feb 2024.
The largest trade he's
ever made was exercising 36,622 units of IONS stock
on 4 Apr 2019. As of 2 Feb 2024
he still owns at least 48,661 units of IONS stock.